SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors

Clinical trial NCT02840149 · COMPLETED

Trial details

NCT number: NCT02840149
Sponsor: Jewish General Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2019-10-01
Primary completion: 2023-12-13
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.